Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

“We are pleased to have reached this new agreement that ensures both eligible SCD and TDT patients can now be treated with Casgevy, recognizing the value a one-time treatment can provide to ...

Investors were feeling zen on Wednesday, with no major news about Donald Trump's tariffs to worry about ahead of the monthly ...

MPS offers to cover part of SROs' salaries, training costs ahead of Feb. 17 deadline ...